Загрузка...
Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry
IMPORTANCE: Transcatheter aortic valve replacement (TAVR) was approved by the US Food and Drug Administration for severe aortic stenosis in patients who cannot undergo surgery and for patients at high operative risk. Use of TAVR for off-label indications has not been previously reported. OBJECTIVE:...
Сохранить в:
| Опубликовано в: : | JAMA Cardiol |
|---|---|
| Главные авторы: | , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Medical Association
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5710589/ https://ncbi.nlm.nih.gov/pubmed/28636718 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2017.1685 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|